TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Nutrition and Physical Activity Environments in Home-based Child Care
Brief Summary: Drs. Patricia Risica (Brown University) and Kim Gans (University of Connecticut) are Dual Principal Investigators for this project. The research team will first conduct formative research using focus groups and key-informant interviews of Family Child Care Home (FCCH) providers. This formative work will inform our adaptation of components of previous evidence-based interventions to create a new innovative intervention in both English and Spanish to improve food and PA environments of Family Child Care Homes (FCCH). The intervention will integrate: a) support from peer counselors with child care experience who will serve as team leaders for groups of FCCPs; b) tailored print and video materials; and c) a set of portable active toys. A cluster-randomized trial with 132 FCCH will evaluate the effectiveness of the intervention with a Steering Committee and Community Advisory Board guiding all aspects. The Specific Aims of the study are to: 1) Conduct formative research to inform the development and adaptation of the FCCH intervention. 2) Conduct a cluster-randomized trial of the intervention's efficacy with 66 FCCH providers and a control intervention with 66 demographically-matched FCCH providers to evaluate its impact on: a) Children's overall dietary quality at FCCHs; b) Children's PA and sedentary behaviors at FCCHs; and c) the physical and social food and PA environments of FCCHs. Evaluation methods will include survey data collection of the FCCH Providers; observation of children's' dietary intake and physical activity in FCCHs; recruitment of children within the FCCH for physical and survey measurement with permission from their parents.


Options:
A: Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Other: Childhood Obesity | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Childhood Obesity; Assigned to Arm(s): Treatment
B: Intervention Type: BEHAVIORAL; Name: attitude change; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: adiposity prevention program; Assigned to Arm(s): N/A
C: Arm Label: parent-targeted intervention; Type: EXPERIMENTAL; Interventions: Behavioral: multi-component/setting parent-targeted intervention | Arm Label: Primary Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: multi-component/setting parent-targeted intervention; Assigned to Arm(s): parent-targeted intervention
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Healthy Food and Physical Activity Environments | Arm Label: Comparison; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Comparison Group | Intervention Type: BEHAVIORAL; Name: Healthy Food and Physical Activity Environments; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Comparison Group; Assigned to Arm(s): Comparison

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Rapid Normalization of Vitamin D in Critically Ill Children: A Phase II Dose Evaluation Randomized Controlled Trial
Brief Summary: Documented roles for vitamin D in calcium homeostasis, cardiovascular and respiratory health, inflammation, innate immunity, and neuromuscular function have led to the hypothesis that deficiency might represent a modifiable risk factor for outcomes in critical illness. In recent years, dozens of adult studies have reported both high deficiency rates, and associations between lower vitamin D levels and organ dysfunction, health resource utilization, and mortality in the intensive care unit (ICU). More recently, similar observations have been made in critically ill pediatric populations. The cumulative body of basic science and clinical literature demonstrates that deficiency is common in critical illness and rapid normalization of vitamin D status could improve clinical outcomes and/or reduce health care costs. However, before conducting a phase III trial to determine whether restoration of vitamin D status improves outcomes in the PICU, the appropriate dosing regimen must be identified. Consequently, the investigators propose a phase II, double blind randomized controlled trial to determine a loading therapy dosing regimen that can safely and rapidly normalize vitamin D status in critically ill children.


Options:
A: Arm Label: Usual care group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: High Dose Group; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Cholecalciferol | Intervention Type: DIETARY_SUPPLEMENT; Name: Cholecalciferol; Assigned to Arm(s): High Dose Group
B: Arm Label: Oral Vitamin D--200 IU/day; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Cholecalciferol | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Arm Label: Oral Vitamin D--800 IU/day; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Cholecalciferol | Intervention Type: DIETARY_SUPPLEMENT; Name: Cholecalciferol; Assigned to Arm(s): Oral Vitamin D--200 IU/day | Intervention Type: DIETARY_SUPPLEMENT; Name: Cholecalciferol; Assigned to Arm(s): Oral Vitamin D--800 IU/day | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Enteral Loading Arm; Type: EXPERIMENTAL; Interventions: Drug: Vitamin D3 | Arm Label: Placebo Arm; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Vitamin D3; Assigned to Arm(s): Enteral Loading Arm | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo Arm
D: Arm Label: monitored group; Type: EXPERIMENTAL; Interventions: Dietary Supplement: monitored vit D supplementation | Arm Label: standard group; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: standard vit D supplementation | Intervention Type: DIETARY_SUPPLEMENT; Name: monitored vit D supplementation; Assigned to Arm(s): monitored group | Intervention Type: DIETARY_SUPPLEMENT; Name: standard vit D supplementation; Assigned to Arm(s): standard group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effectiveness, Superiority and Safety of EA on OAB:Multi-center Randomized Controlled Trial
Brief Summary: The purpose of this study is to determine whether electroacupuncture is effective in the treatment of overactive bladder.


Options:
A: Arm Label: EA; Type: EXPERIMENTAL; Interventions: Other: electroacupncture | Arm Label: Medication; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mirabegron 50 MG [Myrbetriq] | Intervention Type: OTHER; Name: electroacupncture; Assigned to Arm(s): EA | Intervention Type: DRUG; Name: Mirabegron 50 MG [Myrbetriq]; Assigned to Arm(s): Medication
B: Arm Label: Electroacupuncture group; Type: EXPERIMENTAL; Interventions: Device: Electroacupuncture | Arm Label: Placebo group; Type: PLACEBO_COMPARATOR; Interventions: Device: Sham Electroacupuncture | Arm Label: Solifenacin Succinate group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Solifenacin Succinate | Intervention Type: DEVICE; Name: Electroacupuncture; Assigned to Arm(s): Electroacupuncture group | Intervention Type: DEVICE; Name: Sham Electroacupuncture; Assigned to Arm(s): Placebo group | Intervention Type: DRUG; Name: Solifenacin Succinate; Assigned to Arm(s): Solifenacin Succinate group
C: Arm Label: acupuncture; Type: EXPERIMENTAL; Interventions: Procedure: acupuncture | Arm Label: Solifenacin plus PFMT; Type: ACTIVE_COMPARATOR; Interventions: Drug: solifenacin, Procedure: PFMT | Intervention Type: PROCEDURE; Name: acupuncture; Assigned to Arm(s): acupuncture | Intervention Type: DRUG; Name: solifenacin; Assigned to Arm(s): Solifenacin plus PFMT | Intervention Type: PROCEDURE; Name: PFMT; Assigned to Arm(s): Solifenacin plus PFMT
D: Arm Label: Electrical pudendal nerve stimulation; Type: EXPERIMENTAL; Interventions: Behavioral: Electrical pudendal nerve stimulation | Arm Label: PFM training with Transvaginal ES; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: PFM training, Behavioral: Transvaginal ES | Intervention Type: BEHAVIORAL; Name: Electrical pudendal nerve stimulation; Assigned to Arm(s): Electrical pudendal nerve stimulation | Intervention Type: BEHAVIORAL; Name: PFM training; Assigned to Arm(s): PFM training with Transvaginal ES | Intervention Type: BEHAVIORAL; Name: Transvaginal ES; Assigned to Arm(s): PFM training with Transvaginal ES

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effectiveness, Superiority and Safety of EA on OAB:Multi-center Randomized Controlled Trial
Brief Summary: The purpose of this study is to determine whether electroacupuncture is effective in the treatment of overactive bladder.


Options:
A: Arm Label: Exercise training; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise training
B: Arm Label: Electroacupuncture group; Type: EXPERIMENTAL; Interventions: Device: Electroacupuncture | Arm Label: Placebo group; Type: PLACEBO_COMPARATOR; Interventions: Device: Sham Electroacupuncture | Arm Label: Solifenacin Succinate group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Solifenacin Succinate | Intervention Type: DEVICE; Name: Electroacupuncture; Assigned to Arm(s): Electroacupuncture group | Intervention Type: DEVICE; Name: Sham Electroacupuncture; Assigned to Arm(s): Placebo group | Intervention Type: DRUG; Name: Solifenacin Succinate; Assigned to Arm(s): Solifenacin Succinate group
C: Arm Label: Group Bladder Training; Type: EXPERIMENTAL; Interventions: Other: Bladder Training | Arm Label: Group TMAP; Type: ACTIVE_COMPARATOR; Interventions: Other: TMAP | Arm Label: Group Bladder Training + TMAP; Type: ACTIVE_COMPARATOR; Interventions: Other: Bladder Training + TMAP | Intervention Type: OTHER; Name: Bladder Training; Assigned to Arm(s): Group Bladder Training | Intervention Type: OTHER; Name: TMAP; Assigned to Arm(s): Group TMAP | Intervention Type: OTHER; Name: Bladder Training + TMAP; Assigned to Arm(s): Group Bladder Training + TMAP
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Darifenacin | Arm Label: 2; Type: OTHER; Interventions: Drug: Darifenacin, Behavioral: Behavioral therapy | Intervention Type: DRUG; Name: Darifenacin; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Darifenacin; Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: Behavioral therapy; Assigned to Arm(s): 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Precision Dosing Versus Conventional Dosing of Infliximab Maintenance Therapy: a Randomized Controlled Multicenter Study in Patients With IBD in Clinical Remission
Brief Summary: Infliximab (IFX) is highly effective in inducing and maintaining remission in patients with inflammatory bowel disease (IBD). However, a large proportion of patients will eventually lose response to IFX. Therefore, strategies to improve the outcome of maintenance treatment with IFX are required. Retrospective analyses suggest that adjusting IFX treatment in order to achieve IFX trough levels (TL) above a well-defined therapeutic threshold will improve the outcome of IFX treatment.


Options:
A: Arm Label: CT-P13; Type: EXPERIMENTAL; Interventions: Drug: Biosimilar infliximab | Arm Label: INX; Type: ACTIVE_COMPARATOR; Interventions: Drug: Innovator infliximab | Intervention Type: DRUG; Name: Innovator infliximab; Assigned to Arm(s): INX | Intervention Type: DRUG; Name: Biosimilar infliximab; Assigned to Arm(s): CT-P13
B: Arm Label: PRECISION dosing; Type: EXPERIMENTAL; Interventions: Drug: PRECISION dosing Infliximab | Arm Label: Conventional dosing of Infliximab; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: PRECISION dosing Infliximab; Assigned to Arm(s): PRECISION dosing
C: Arm Label: Infliximab; Type: EXPERIMENTAL; Interventions: Biological: Infliximab | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: BIOLOGICAL; Name: Infliximab; Assigned to Arm(s): Infliximab | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Usual Care practice; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Treatment Algorithm; Type: ACTIVE_COMPARATOR; Interventions: Other: Treatment Algorithm for Crohn's Disease | Intervention Type: OTHER; Name: Treatment Algorithm for Crohn's Disease; Assigned to Arm(s): Treatment Algorithm

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Double-blind, Placebo-controlled Cross-over Study of Inhaled Alginate Oligosaccharide (OligoG) for 28 Days in Subjects With Cystic Fibrosis Using Aztreonam Due to Chronic Colonization With Burkholderia Spp.
Brief Summary: The purpose of the study is to assess the efficacy of Alginate oligosaccharide (OligoG) dry powder for inhalation in cystic fibrosis (CF) patients with a Burkholderia spp. infection.


Options:
A: Arm Label: Alginate oligosaccharide; Type: ACTIVE_COMPARATOR; Interventions: Drug: Alginate oligosaccharide | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Alginate oligosaccharide; Assigned to Arm(s): Alginate oligosaccharide | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: VX-445/TEZ/IVA TC; Type: EXPERIMENTAL; Interventions: Drug: VX-445/TEZ/IVA, Drug: IVA | Intervention Type: DRUG; Name: VX-445/TEZ/IVA; Assigned to Arm(s): VX-445/TEZ/IVA TC | Intervention Type: DRUG; Name: IVA; Assigned to Arm(s): VX-445/TEZ/IVA TC | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Arm Label: Prebiotic; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Prebiotic | Intervention Type: DIETARY_SUPPLEMENT; Name: Prebiotic; Assigned to Arm(s): Prebiotic | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Placebo (pooled two times a day [BID]/three times a day [TID]); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo two times a day (BID)/three times a day (TID) | Arm Label: AZLI (pooled two times a day [BID]/three times a day [TID]); Type: EXPERIMENTAL; Interventions: Drug: AZLI 75 mg two times a day (BID)/three times a day (TID) | Intervention Type: DRUG; Name: AZLI 75 mg two times a day (BID)/three times a day (TID); Assigned to Arm(s): AZLI (pooled two times a day [BID]/three times a day [TID]) | Intervention Type: DRUG; Name: Placebo two times a day (BID)/three times a day (TID); Assigned to Arm(s): Placebo (pooled two times a day [BID]/three times a day [TID])

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pre-surgery Physiotherapy for Patients With Specific Low Back Pain , RCT
Brief Summary: The aim is to study if pre-surgery physiotherapy improves function, pain and health in patients with specific low back pain scheduled for surgery. Patients are followed over a two year period. A secondary aim is to study what factors predict short and long term outcomes.


Options:
A: Arm Label: Pre-surgery physiotherapy; Type: OTHER; Interventions: Other: Pre-surgery physiotherapy | Arm Label: Waiting-list; Type: OTHER; Interventions: Other: Waiting-list | Intervention Type: OTHER; Name: Pre-surgery physiotherapy; Assigned to Arm(s): Pre-surgery physiotherapy | Intervention Type: OTHER; Name: Waiting-list; Assigned to Arm(s): Waiting-list
B: Arm Label: Exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise | Arm Label: Standard nutrition counselling; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise
C: Arm Label: multimodal prehabilitation begun preop; Type: EXPERIMENTAL; Interventions: Behavioral: multimodal prehabilitation | Arm Label: Multimodal prehabilitation begun postop; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: multimodal prehabilitation | Intervention Type: BEHAVIORAL; Name: multimodal prehabilitation; Assigned to Arm(s): multimodal prehabilitation begun preop | Intervention Type: BEHAVIORAL; Name: multimodal prehabilitation; Assigned to Arm(s): Multimodal prehabilitation begun postop
D: Arm Label: Exercise Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise Intervention | Arm Label: Control Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise Intervention; Assigned to Arm(s): Exercise Intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pre-surgery Physiotherapy for Patients With Specific Low Back Pain , RCT
Brief Summary: The aim is to study if pre-surgery physiotherapy improves function, pain and health in patients with specific low back pain scheduled for surgery. Patients are followed over a two year period. A secondary aim is to study what factors predict short and long term outcomes.


Options:
A: Arm Label: Pre and postoperative exercise; Type: EXPERIMENTAL; Interventions: Other: Physical activity | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Physical activity; Assigned to Arm(s): Pre and postoperative exercise
B: Arm Label: HIT; Type: EXPERIMENTAL; Interventions: Procedure: HIT | Arm Label: MCT; Type: ACTIVE_COMPARATOR; Interventions: Procedure: MCT | Intervention Type: PROCEDURE; Name: HIT; Assigned to Arm(s): HIT | Intervention Type: PROCEDURE; Name: MCT; Assigned to Arm(s): MCT
C: Arm Label: Pre-surgery physiotherapy; Type: OTHER; Interventions: Other: Pre-surgery physiotherapy | Arm Label: Waiting-list; Type: OTHER; Interventions: Other: Waiting-list | Intervention Type: OTHER; Name: Pre-surgery physiotherapy; Assigned to Arm(s): Pre-surgery physiotherapy | Intervention Type: OTHER; Name: Waiting-list; Assigned to Arm(s): Waiting-list
D: Arm Label: Exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise programme | Arm Label: No Exercise; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise programme; Assigned to Arm(s): Exercise

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Electronic Warning System to Improve Stroke Prevention in Atrial Fibrillation - A Quality Improvement Initiative at the University Hospital Bern
Brief Summary: The aim of this randomized controlled study is to evaluate whether a newly designed electronic warning system will increase the initiation rate of adequate stroke preventive measures in patients with atrial fibrillation.


Options:
A: Arm Label: Electronic alert; Type: ACTIVE_COMPARATOR; Interventions: Other: Electronic warning alert | Arm Label: No electronic alert; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Electronic warning alert; Assigned to Arm(s): Electronic alert
B: Arm Label: Standard (static) Computer Alerts; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard (static) Computer Alerts | Arm Label: Enhanced Computer Alerts; Type: EXPERIMENTAL; Interventions: Other: Enhanced Computer Alerts | Intervention Type: OTHER; Name: Standard (static) Computer Alerts; Assigned to Arm(s): Standard (static) Computer Alerts | Intervention Type: OTHER; Name: Enhanced Computer Alerts; Assigned to Arm(s): Enhanced Computer Alerts
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Other: automated clinical alerts, Other: provider education | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: provider education | Intervention Type: OTHER; Name: automated clinical alerts; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: provider education; Assigned to Arm(s): 1, 2
D: Arm Label: Notification Group; Type: EXPERIMENTAL; Interventions: Behavioral: Notification Group | Arm Label: No Notification; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Notification Group; Assigned to Arm(s): Notification Group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Counseling During Pulmonary Rehabilitation on Self-determined Motivation Towards Physical Activity in Patients With Chronic Obstructive Pulmonary Disease
Brief Summary: The purpose of this study is to investigate if a physical activity counseling program during pulmonary rehabilitation increases the physical activity level in daily life in patients with Chronic Obstructive Pulmonary Disease.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: physical activity counseling program | Arm Label: 2; Type: SHAM_COMPARATOR; Interventions: Behavioral: sham counseling program | Intervention Type: BEHAVIORAL; Name: physical activity counseling program; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: sham counseling program; Assigned to Arm(s): 2
B: Arm Label: Pulmonary Rehabilitation Group; Type: EXPERIMENTAL; Interventions: Behavioral: Pulmonary Intervention | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Pulmonary Intervention; Assigned to Arm(s): Pulmonary Rehabilitation Group
C: Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Arm Label: Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: physical activity counseling | Intervention Type: BEHAVIORAL; Name: physical activity counseling; Assigned to Arm(s): Counseling | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Usual Care
D: Arm Label: CST; Type: EXPERIMENTAL; Interventions: Behavioral: Telephone-based Enhanced Coping Skills Training (CST) | Arm Label: UMC; Type: OTHER; Interventions: Other: Usual Medical Care and COPD education and symptom monitoring (UMC) | Intervention Type: BEHAVIORAL; Name: Telephone-based Enhanced Coping Skills Training (CST); Assigned to Arm(s): CST | Intervention Type: OTHER; Name: Usual Medical Care and COPD education and symptom monitoring (UMC); Assigned to Arm(s): UMC

Answer: C